Preventing deep wound infection after coronary artery bypass grafting: A review

Texas Heart Institute Journal

Volumn 40, Issue 2, 2013, Pages 125-139

  Bryan, Charles S ^a   Yarbrough, William M ^a  

^a Sisters of Charity Providence Hospitals   (United States)

Author keywords

Anti bacterial agents administration and Dosage therapeutic use; Antibiotic prophylaxis methods Standards; Bacterial infections prevention; Clinical trials as topic; Control; Coronary artery bypass adverse effects; Mediastinitis prevention and Control; Postoperative complications; Prevention and Control; Quality assurance health care methods; Risk factors; Surgical wound infection prevention

Indexed keywords

CEFAZOLIN; CEFUROXIME; DAPTOMYCIN; NAFCILLIN; OXACILLIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ASSISTED CIRCULATION; BACTERIAL COLONIZATION; BLOOD TRANSFUSION; BODY MASS; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; DEEP WOUND INFECTION; DIABETES MELLITUS; DRUG DOSE COMPARISON; HEALTH CARE QUALITY; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MEDIASTINITIS; MEDICAL AUDIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; NOSE INFECTION; OBESITY; PATHOGENESIS; PATIENT CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; REOPERATION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SCORING SYSTEM; SURGICAL RISK; TREATMENT DURATION; WOUND INFECTION;

ANTI-BACTERIAL AGENTS/ADMINISTRATION & DOSAGE/THERAPEUTIC USE; ANTIBIOTIC PROPHYLAXIS/METHODS/STANDARDS; BACTERIAL INFECTIONS/PREVENTION & CONTROL; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY BYPASS/ADVERSE EFFECTS; MEDIASTINITIS/PREVENTION & CONTROL; POSTOPERATIVE COMPLICATIONS/PREVENTION & CONTROL; QUALITY ASSURANCE/HEALTH CARE/METHODS; RISK FACTORS; SURGICAL WOUND INFECTION/PREVENTION & CONTROL;

ANTIBIOTIC PROPHYLAXIS; CORONARY ARTERY BYPASS; GUIDELINE ADHERENCE; HUMANS; INFECTION CONTROL; LOGISTIC MODELS; MEDIASTINITIS; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; RISK ASSESSMENT; RISK FACTORS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 84878087532     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Review

References (213)

1. Hollenbeak CS, Murphy DM, Koenig S, Woodward RS, Dunagan WC, Fraser VJ. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest 2000;118(2):397-402.
2. Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR; Society of Thoracic Surgeons. The Society of Thoracic Surgeons Practice Guideline Series: antibiotic prophylaxis in cardiac surgery, part I: duration. Ann Thorac Surg 2006;81 (1):397-404.
3. Ferris TG, Torchiana DF. Public release of clinical outcomes data-online CABG report cards. N Engl J Med 2010;363(17): 1593-5.
4. Masud F, Vykoukal D. Preventing healthcare-associated infections in cardiac surgical patients as a hallmark of excellence. Methodist DeBakey Cardiovasc J 2011;7(2):48-50.
5. Fernandez-Ayala M, Nan DN, Farinas-Alvarez C, Revuelta JM, Gonzalez-Macias J, Farinas MC. Surgical site infection during hospitalization and after discharge in patients who have undergone cardiac surgery. Infect Control Hosp Epidemiol 2006;27(1):85-8.
6. Wiley AM, Ha'eri GB. Routes of infection. A study of using "tracer particles" in the orthopedic operating room. Clin Orthop Relat Res 1979(139):150-5.
7. Yap CH, Mohajeri M, Yii M. Obesity and early complications after cardiac surgery. Med J Aust 2007;186(7):350-4.
8. McDonald WS, Brame M, Sharp C, Eggerstedt J. Risk factors for median sternotomy dehiscence in cardiac surgery. South Med J 1989;82(11):1361-4.
9. Loop FD, Lytle BW, Cosgrove DM, Mahfood S, McHenry MC, Goormastic M, et al. J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 1990;49(2):179-87.
10. Grossi EA, Esposito R, Harris LJ, Crooke GA, Galloway AC, Colvin SB, et al. Sternal wound infections and use of internal mammary artery grafts. J Thorac Cardiovasc Surg 1991;102 (3):342-7.
11. Wouters R, Wellens F, Vanermen H, De Geest R, Degrieck I, De Meerleer F. Sternitis and mediastinitis after coronary artery bypass grafting. Analysis of risk factors. Tex Heart Inst J 1994;21(3):183-8.
12. Ridderstolpe L, Gill H, Granfeldt H, Ahlfeldt H, Rutberg H. Superficial and deep sternal wound complications: incidence, risk factors and mortality. Eur J Cardiothorac Surg 2001;20 (6):1168-75.
13. Gummert JF, Barten MJ, Hans C, Kluge M, Doll N, Walther T, et al. Mediastinitis and cardiac surgery--an updated risk factor analysis in 10,373 consecutive adult patients. Thorac Cardiovasc Surg 2002;50(2):87-91.
14. Russo PL, Spelman DW. A new surgical-site infection risk index using risk factors identified by multivariate analysis for patients undergoing coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2002;23(7):372-6.
15. Kohli M, Yuan L, Escobar M, David T, Gillis G, Comm B, et al. A risk index for sternal surgical wound infection after cardiovascular surgery. Infect Control Hosp Epidemiol 2003;24 (1):17-25.
16. Crabtree TD, Codd JE, Fraser VJ, Bailey MS, Olsen MA, Damiano RJ Jr. Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center. Semin Thorac Cardiovasc Surg 2004;16(1):53-61.
17. Dodds Ashley ES, Carroll DN, Engemann JJ, Harris AD, Fowler VG Jr, Sexton DJ, Kaye KS. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004;38(11):1555-60.
18. Harrington G, Russo P, Spelman D, Borrell S, Watson K, Barr W, et al. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2004;25(6):472-6.
19. Fowler VG Jr, O'Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED. Clinical predictors of major infections after cardiac surgery. Circulation 2005;112(9 Suppl):I358-65.
20. Garey KW, Kumar N, Dao T, Tam VH, Gentry LO. Risk factors for postoperative chest wound infections due to gramnegative bacteria in cardiac surgery patients. J Chemother 2006;18(4):402-8.
21. Simsek Yavuz S, Bicer Y, Yapici N, Kalaca S, Aydin OO, Camur G, et al. Analysis of risk factors for sternal surgical site infection: emphasizing the appropriate ventilation of the operating theaters. Infect Control Hosp Epidemiol 2006;27(9): 958-63.
22. Fakih MG, Sharma M, Khatib R, Berriel-Cass D, Meisner S, Harrington S, Saravolatz L. Increase in the rate of sternal surgical site infection after coronary artery bypass graft: a marker of higher severity of illness. Infect Control Hosp Epidemiol 2007;28(6):655-60.
23. Robinson PJ, Billah B, Leder K, Reid CM; ASCTS Database Committee. Factors associated with deep sternal wound infection and haemorrhage following cardiac surgery in Victoria. Interact Cardiovasc Thorac Surg 2007;6(2):167-71.
24. Cayci C, Russo M, Cheema FH, Martens T, Ozcan V, Argenziano M, et al. Risk analysis of deep sternal wound infections and their impact on long-term survival: a propensity analysis. Ann Plast Surg 2008;61(3):294-301.
25. Filsoufi F, Castillo JG, Rahmanian PB, Broumand SR, Silvay G, Carpentier A, Adams DH. Epidemiology of deep sternal wound infection in cardiac surgery. J Cardiothorac Vasc Anesth 2009;23(4):488-94.
26. Graf K, Sohr D, Haverich A, Kuhn C, Gastmeier P, Chaberny IF. Decrease of deep sternal surgical site infection rates after cardiac surgery by a comprehensive infection control program. Interact Cardiovasc Thorac Surg 2009;9(2):282-6.
27. Risnes I, Abdelnoor M, Almdahl SM, Svennevig JL. Mediastinitis after coronary artery bypass grafting risk factors and long-term survival. Ann Thorac Surg 2010;89(5):1502-9.
28. Lola I, Levidiotou S, Petrou A, Arnaoutoglou H, Apostolakis E, Papadopoulos GS. Are there independent predisposing factors for postoperative infections following open heart surgery? J Cardiothorac Surg 2011;6:151.
29. Sa MP, Soares EF, Santos CA, Figueiredo OJ, Lima RO, Escobar RR, et al. Risk factors for mediastinitis after coronary artery bypass grafting surgery. Rev Bras Cir Cardiovasc 2011; 26(1):27-35.
30. Milano CA, Kesler K, Archibald N, Sexton DJ, Jones RH. Mediastinitis after coronary artery bypass graft surgery. Risk factors and long-term survival. Circulation 1995;92(8):2245-51.
31. The Parisian Mediastinitis Study Group. Risk factors for deep sternal wound infection after sternotomy: a prospective, multicenter study. J Thorac Cardiovasc Surg 1996;111(6):1200-7.
32. Bitkover CY, Gardlund B. Mediastinitis after cardiovascular operations: a case-control study of risk factors. Ann Thorac Surg 1998;65(1):36-40.
33. Abboud CS, Wey SB, Baltar VT. Risk factors for mediastinitis after cardiac surgery. Ann Thorac Surg 2004;77(2):676-83.
34. Lucet JC; Parisian Mediastinitis Study Group. Surgical site infection after cardiac surgery: a simplified surveillance method. Infect Control Hosp Epidemiol 2006;27(12):1393-6.
35. Diez C, Koch D, Kuss O, Silber RE, Friedrich I, Boergermann J. Risk factors for mediastinitis after cardiac surgery-a retrospective analysis of 1700 patients. J Cardiothorac Surg 2007;2:23.
36. Shaikhrezai K, Robertson FL, Anderson SE, Slight RD, Brackenbury ET. Does the number of wires used to close a sternotomy have an impact on deep sternal wound infection? Interact Cardiovasc Thorac Surg 2012;15(2):219-22.
37. Newman LS, Szczukowski LC, Bain RP, Perlino CA. Suppurative mediastinitis after open heart surgery. A case control study of risk factors. Chest 1988;94(3):546-53.
38. Ku CH, Ku SL, Yin JC, Lee AJ. Risk factors for sternal and leg surgical site infections after cardiac surgery in Taiwan. Am J Epidemiol 2005;161(7):661-71.
39. Berrios-Torres SI, Mu Y, Edwards JR, Horan TC, Fridkin SK. Improved risk adjustment in public reporting: coronary artery bypass graft surgical site infections. Infect Control Hosp Epidemiol 2012;33(5):463-9.
40. Ottino G, De Paulis R, Pansini S, Rocca G, Tallone MV, Comoglio C, et al. Major sternal wound infection after openheart surgery: a multivariate analysis of risk factors in 2,579 consecutive operative procedures. Ann Thorac Surg 1987;44 (2):173-9.
41. Lin CH, Hsu RB, Chang SC, Lin FY, Chu SH. Poststernotomy mediastinitis due to methicillin-resistant Staphylococcus aureus endemic in a hospital. Clin Infect Dis 2003;37(5):679-84.
42. Sakamoto H, Fukuda I, Oosaka M, Nakata H. Risk factors and treatment of deep sternal wound infection after cardiac operation. Ann Thorac Cardiovasc Surg 2003;9(4):226-32.
43. Lepelletier D, Perron S, Bizouarn P, Caillon J, Drugeon H, Michaud JL, Duveau D. Surgical-site infection after cardiac surgery: incidence, microbiology, and risk factors. Infect Control Hosp Epidemiol 2005;26(5):466-72.
44. Salehi Omran A, Karimi A, Ahmadi SH, Davoodi S, Marzban M, Movahedi N, et al. Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality. BMC Infect Dis 2007;7:112.
45. Centofanti P, Savia F, La Torre M, Ceresa F, Sansone F, Veglio V, et al. A prospective study of prevalence of 60-days postoperative wound infections after cardiac surgery. An updated risk factor analysis. J Cardiovasc Surg (Torino) 2007; 48(5): 641-6.
46. Demmy TL, Park SB, Liebler GA, Burkholder JA, Maher TD, Benckart DH, et al. Recent experience with major sternal wound complications. Ann Thorac Surg 1990;49(3):458-62.
47. Lee YP, Feng MC, Wu LC, Chen SH, Chen YH, Chiu CC, et al. Outcome and risk factors associated with surgical site infections after cardiac surgery in a Taiwan medical center. J Microbiol Immunol Infect 2010;43(5):378-85.
48. Zhang L, Garcia JM, Hill PC, Haile E, Light JA, Corso PJ. Cardiac surgery in renal transplant recipients: experience from Washington Hospital Center. Ann Thorac Surg 2006;81(4): 1379-84.
49. Gualis J, Florez S, Tamayo E, Alvarez FJ, Castrodeza J, Castano M. Risk factors for mediastinitis and endocarditis after cardiac surgery. Asian Cardiovasc Thorac Ann 2009;17(6): 612-6.
50. Kim DH, Shim JK, Hong SW, Cho KR, Kang SY, Kwak YL. Predictive value of C-reactive protein for major postoperative complications following off-pump coronary artery bypass surgery: prospective and observational trial. Circ J 2009;73(5): 872-7.
51. Copeland M, Senkowski C, Ulcickas M, Mendelson M, Griepp RB. Breast size as a risk factor for sternal wound complications following cardiac surgery. Arch Surg 1994;129(7): 757-9.
52. Cappabianca G, Paparella D, Visicchio G, Capone G, Lionetti G, Numis F, et al. Preoperative C-reactive protein predicts mid-term outcome after cardiac surgery. Ann Thorac Surg 2006;82(6):2170-8.
53. Mikkelsen MM, Andersen NH, Christensen TD, Hansen TK, Eiskjaer H, Gjedsted J, et al. Microalbuminuria is associated with high adverse event rate following cardiac surgery. Eur J Cardiothorac Surg 2011;39(6):932-8.
54. Attaran S, Shaw M, Bond L, Pullan MD, Fabri BM. A comparison of outcome in patients with preoperative atrial fibrillation and patients in sinus rhythm. Ann Thorac Surg 2011;92 (4):1391-5.
55. Kaw R, Golish J, Ghamande S, Burgess R, Foldvary N, Walker E. Incremental risk of obstructive sleep apnea on cardiac surgical outcomes. J Cardiovasc Surg (Torino) 2006;47(6):683-9.
56. Force SD, Miller DL, Petersen R, Mansour KA, Craver J, Guyton RA, Miller JI Jr. Incidence of deep sternal wound infections after tracheostomy in cardiac surgery patients. Ann Thorac Surg 2005;80(2):618-22.
57. Rahmanian PB, Adams DH, Castillo JG, Chikwe J, Filsoufi F. Tracheostomy is not a risk factor for deep sternal wound infection after cardiac surgery. Ann Thorac Surg 2007;84(6): 1984-91.
58. Sommer SP, Lange V, Yildirim C, Schimmer C, Aleksic I, Wagner C, et al. Cardiac surgery and hematologic malignancies: a retrospective single-center analysis of 56 consecutive patients. Eur J Cardiothorac Surg 2011;40(1):173-8.
59. Attaran S, Shaw M, Bond L, Pullan MD, Fabri BM. Atrial fibrillation postcardiac surgery: a common but a morbid complication. Interact Cardiovasc Thorac Surg 2011;12(5):772-7.
60. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32(8):470-85.
61. Haley VB, Van Antwerpen C, Tsivitis M, Doughty D, Gase KA, Hazamy P, et al. Risk factors for coronary artery bypass graft chest surgical site infections in New York State, 2008. Am J Infect Control 2012;40(1):22-8.
62. Friedman ND, Bull AL, Russo PL, Gurrin L, Richards M. Performance of the National Nosocomial Infections Surveillance risk index in predicting surgical site infection in Australia. Infect Control Hosp Epidemiol 2007;28(1):55-9.
63. Friedman ND, Russo PL, Bull AL, Richards MJ, Kelly H. Validation of coronary artery bypass graft surgical site infection surveillance data from a statewide surveillance system in Australia. Infect Control Hosp Epidemiol 2007;28(7):812-7.
64. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16(1):9-13.
65. Paul M, Raz A, Leibovici L, Madar H, Holinger R, Rubinovitch B. Sternal wound infection after coronary artery bypass graft surgery: validation of existing risk scores. J Thorac Cardiovasc Surg 2007;133(2):397-403.
66. Chen LF, Anderson DJ, Kaye KS, Sexton DJ. Validating a 3-point prediction rule for surgical site infection after coronary artery bypass surgery. Infect Control Hosp Epidemiol 2010;31(1):64-8.
67. Ferraris VA, Ferraris SP, Moliterno DJ, Camp P, Walenga JM, Messmore HL, et al. The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg 2005;79(4):1454-61.
68. Ferrandis R, Llau JV, Mugarra A. Perioperative management of antiplatelet-drugs in cardiac surgery. Curr Cardiol Rev 2009;5(2):125-32.
69. Fitchett D, Eikelboom J, Fremes S, Mazer D, Singh S, Bittira B, et al. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Can J Cardiol 2009;25(12):683-9.
70. Gurbel PA, Mahla E, Tantry US. Peri-operative platelet function testing: the potential for reducing ischaemic and bleeding risks. Thromb Haemost 2011;106(2):248-52.
71. Biancari F, Airaksinen KE, Lip GY. Benef its and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies. J Thorac Cardiovasc Surg 2012;143(3): 665-75. e4.
72. McBride T, Beamer J. Pre-operative patient preparation in the prevention of surgical site infections. Can Oper Room Nurs J 2007;25(4):26-7, 29-32, 4.
73. Mohamed R, McAlister FA, Pretorius V, Kapoor AS, Majumdar SR, Ross DB, et al. Preoperative statin use and infection after cardiac surgery: a cohort study. Clin Infect Dis 2009;48 (7):e66-72.
74. Tleyjeh IM, Alasmari FA, Bin Abdulhak AA, Riaz M, Garbati MA, Erwin PJ, et al. Association between preoperative statin therapy and postoperative infectious complications in patients undergoing cardiac surgery: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2012;33(11): 1143-51.
75. Tepaske R, Velthuis H, Oudemans-van Straaten HM, Heisterkamp SH, van Deventer SJ, Ince C, et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 2001;358(9283):696-701.
76. Tepaske R, te Velthuis H, Oudemans-van Straaten HM, Bossuyt PM, Schultz MJ, Eijsman L, Vroom M. Glycine does not add to the beneficial effects of perioperative oral immune-enhancing nutrition supplements in high-risk cardiac surgery patients. JPEN J Parenter Enteral Nutr 2007;31(3): 173-80.
77. Strecker T, Rosch J, Horch RE, Weyand M, Kneser U. Sternal wound infections following cardiac surgery: risk factor analysis and interdisciplinary treatment. Heart Surg Forum 2007;10(5):E366-71.
78. Tom TS, Kruse MW, Reichman RT. Update: methicillin-resistant Staphylococcus aureus screening and decolonization in cardiac surgery. Ann Thorac Surg 2009;88(2):695-702.
79. Butterly A, Schmidt U, Wiener-Kronish J. Methicillin-resistant Staphylococcus aureus colonization, its relationship to nosocomial infection, and efficacy of control methods. Anesthesiology 2010;113(6):1453-9.
80. Banbury MK. Experience in prevention of sternal wound infections in nasal carriers of Staphylococcus aureus. Surgery 2003;134(5 Suppl):S18-25.
81. Nicholson MR, Huesman LA. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control 2006;34(1):44-8.
82. Combes A, Trouillet JL, Joly-Guillou ML, Chastre J, Gibert C. The impact of methicillin resistance on the outcome of poststernotomy mediastinitis due to Staphylococcus aureus. Clin Infect Dis 2004;38(6):822-9.
83. Reddy SL, Grayson AD, Smith G, Warwick R, Chalmers JA. Methicillin resistant Staphylococcus aureus infections following cardiac surgery: incidence, impact and identifying adverse outcome traits. Eur J Cardiothorac Surg 2007;32(1): 113-7.
84. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001;344(1):11-6.
85. Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med 2011;171(1): 68-73.
86. Engelman R, Shahian D, Shemin R, Guy TS, Bratzler D, Edwards F, et al. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice. Ann Thorac Surg 2007;83(4):1569-76.
87. Konvalinka A, Errett L, Fong IW. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J Hosp Infect 2006;64(2):162-8.
88. van Rijen MM, Bonten M, Wenzel RP, Kluytmans JA. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother 2008;61(2):254-61.
89. Trautmann M, Stecher J, Hemmer W, Luz K, Panknin HT. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies. Chemotherapy 2008;54(1):9-16.
90. San Juan R, Chaves F, Lopez Gude MJ, Diaz-Pedroche C, Otero J, Cortina Romero JM, et al. Staphylococcus aureus poststernotomy mediastinitis: description of two distinct acquisition pathways with different potential preventive approaches [published erratum appears in J Thorac Cardiovasc Surg 2008;136(2):542]. J Thorac Cardiovasc Surg 2007;134 (3):670-6.
91. Harbarth S, Huttner B, Gervaz P, Fankhauser C, Chraiti MN, Schrenzel J, et al. Risk factors for methicillin-resistant Staphylococcus aureus surgical site infection. Infect Control Hosp Epidemiol 2008;29(9):890-3.
92. Mohammad ZU, Yasin K, Niaz A, Aurangzeb D, Mohammad KA, Mohammad R. Incidence and outcome of nasal and groin methicillin-resistant Staphylococcus aureus carrier state in patients admitted for routine cardiac surgery. JPMI 2008; 22(1):21-6. Available from: http://www.jpmi.org.pk/index. php/jpmi/article/view/243/155 [cited 2013 Feb 11].
93. Carrier M, Marchand R, Auger P, Hebert Y, Pellerin M, Perrault LP, et al. Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit. J Thorac Cardiovasc Surg 2002;123(1):40-4.
94. Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 1998;41(1):11-8.
95. Tenover FC, Tickler IA, Goering RV, Kreiswirth BN, Mediavilla JR, Persing DH; MRSA Consortium. Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States hospitals. Antimicrob Agents Chemother 2012;56(3):1324-30.
96. Reiss S, Pane-Farre J, Fuchs S, Francois P, Liebeke M, Schrenzel J, et al. Global analysis of the Staphylococcus aureus response to mupirocin. Antimicrob Agents Chemother 2012;56 (2):787-804.
97. Seah C, Alexander DC, Louie L, Simor A, Low DE, Longtin J, Melano RG. MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus. Antimicrob Agents Chemother 2012;56(4):1916-20.
98. Courville XF, Tomek IM, Kirkland KB, Birhle M, Kantor SR, Finlayson SR. Cost-effectiveness of preoperative nasal mupirocin treatment in preventing surgical site infection in patients undergoing total hip and knee arthroplasty: a cost-effectiveness analysis. Infect Control Hosp Epidemiol 2012;33 (2):152-9.
99. Strymish J, Branch-Elliman W, Itani KM, Williams S, Gupta K. A clinical history of methicillin-resistant Staphylococcus aureus is a poor predictor of preoperative colonization status and postoperative infections. Infect Control Hosp Epidemiol 2012;33(11):1113-7.
100. Shrestha NK, Banbury MK, Weber M, Cwynar RE, Lober C, Procop GW, et al. Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery. Ann Thorac Surg 2006;81(6):2183-8.
101. Jog S, Cunningham R, Cooper S, Wallis M, Marchbank A, Vasco-Knight P, Jenks PJ. Impact of preoperative screening for methicillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery. J Hosp Infect 2008;69(2):124-30.
102. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010;362(1):9-17.
103. Lee BY, Wiringa AE, Bailey RR, Goyal V, Lewis GJ, Tsui BY, et al. Screening cardiac surgery patients for MRSA: an economic computer model. Am J Manag Care 2010;16(7):e163-73.
104. Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 2006;296(20):2460-6.
105. Kamel C, McGahan L, Polisena J, Mierzwinski-Urban M, Embil JM. Preoperative skin antiseptic preparations for preventing surgical site infections: a systematic review. Infect Control Hosp Epidemiol 2012;33(6):608-17.
106. Kuhme T, Isaksson B, Dahlin LG. Wound contamination in cardiac surgery. A systematic quantitative and qualitative study of the bacterial growth in sternal wounds in cardiac surgery patients. APMIS 2007;115(9):1001-7.
107. Goodman JS, Schaffner W, Collins HA, Battersby EJ, Koenig MG. Infection after cardiovascular surgery. Clinical study including examination of antimicrobial prophylaxis. N Engl J Med 1968;278(3):117-23.
108. Bratzler DW, Houck PM, Richards C, Steele L, Dellinger EP, Fry DE, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005;140(2):174-82.
109. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006;43(3):322-30.
110. Alexiou VG, Ierodiakonou V, Peppas G, Falagas ME. Antimicrobial prophylaxis in surgery: an international survey. Surg Infect (Larchmt) 2010;11(4):343-8.
111. Zanetti G, Giardina R, Platt R. Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery. Emerg Infect Dis 2001;7(5):828-31.
112. Zanetti G, Flanagan HL Jr, Cohn LH, Giardina R, Platt R. Improvement of intraoperative antibiotic prophylaxis in prolonged cardiac surgery by automated alerts in the operating room. Infect Control Hosp Epidemiol 2003;24(1):13-6.
113. Caffarelli AD, Holden JP, Baron EJ, Lemmens HJ, D'Souza H, Yau V, et al. Plasma cefazolin levels during cardiovascular surgery: effects of cardiopulmonary bypass and profound hypothermic circulatory arrest. J Thorac Cardiovasc Surg 2006; 131(6):1338-43.
114. Tamayo E, Gualis J, Florez S, Castrodeza J, Eiros Bouza JM, Alvarez FJ. Comparative study of single-dose and 24-hour multiple-dose antibiotic prophylaxis for cardiac surgery. J Thorac Cardiovasc Surg 2008;136(6):1522-7.
115. Adembri C, Ristori R, Chelazzi C, Arrigucci S, Cassetta MI, De Gaudio AR, Novelli A. Cefazolin bolus and continuous administration for elective cardiac surgery: improved pharmacokinetic and pharmacodynamic parameters. J Thorac Cardiovasc Surg 2010;140(2):471-5.
116. Edmiston CE, Krepel C, Kelly H, Larson J, Andris D, Hennen C, et al. Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels? Surgery 2004;136(4):738-47.
117. Paul M, Porat E, Raz A, Madar H, Fein S, Bishara J, et al. Duration of antibiotic prophylaxis for cardiac surgery: prospective observational study. J Infect 2009;58(4):291-8.
118. Kallman J, Friberg O. Antibiotic prophylaxis in cardiac surgery--general principles. APMIS 2007;115(9):1012-5.
119. Mertz D, Johnstone J, Loeb M. Does duration of perioperative antibiotic prophylaxis matter in cardiac surgery? A systematic review and meta-analysis. Ann Surg 2011;254(1):48-54.
120. Crawford T, Rodvold KA, Solomkin JS. Vancomycin for surgical prophylaxis? Clin Infect Dis 2012;54(10):1474-9.
121. Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg 2002;123(2):326-32.
122. Kachroo S, Dao T, Zabaneh F, Reiter M, Larocco MT, Gentry LO, Garey KW. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization. Ann Pharmacother 2006;40(3):381-5.
123. Garey KW, Dao T, Chen H, Amrutkar P, Kumar N, Reiter M, Gentry LO. Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections. J Antimicrob Chemother 2006;58(3):645-50.
124. Movahed MR, Kasravi B, Bryan CS. Prophylactic use of vancomycin in adult cardiology and cardiac surgery. J Cardiovasc Pharmacol Ther 2004;9(1):13-20.
125. Raikhelkar JK, Reich DL, Schure R, Varghese R, Bodian C, Scurlock C. The efficacy of post-cardiopulmonary bypass dosing of vancomycin in cardiac surgery. Semin Cardiothorac Vasc Anesth 2010;14(4):301-4.
126. Grace E. Altered vancomycin pharmacokinetics in obese and morbidly obese patients: what we have learned over the past 30 years. J Antimicrob Chemother 2012;67(6):1305-10.
127. Garey KW, Lai D, Dao-Tran TK, Gentry LO, Hwang LY, Davis BR. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother 2008;52(2):446-51.
128. Bolon MK, Morlote M, Weber SG, Koplan B, Carmeli Y, Wright SB. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis 2004;38(10):1357-63.
129. Kappeler R, Gillham M, Brown NM. Antibiotic prophylaxis for cardiac surgery. J Antimicrob Chemother 2012;67(3):521-2.
130. Lador A, Nasir H, Mansur N, Sharoni E, Biderman P, Leibovici L, Paul M. Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis. J Antimicrob Chemother 2012;67(3):541-50.
131. Bryan CS, Morgan SL, Jordan AB, Smith CW, Sutton JP, Gangemi JD. Ceftriaxone levels in blood and tissue during cardiopulmonary bypass surgery. Antimicrob Agents Chemother 1984;25(1):37-9.
132. Salminen US, Viljanen TU, Valtonen VV, Ikonen TE, Sahlman AE, Harjula AL. Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery. J Antimicrob Chemother 1999;44(2):287-90.
133. Vandecasteele SJ, Boelaert JR, Verrelst P, Graulus E, Gordts BZ. Diagnosis and treatment of Aspergillus f lavus sternal wound infections after cardiac surgery. Clin Infect Dis 2002; 35(7):887-90.
134. Heinemann S, Symoens F, Gordts B, Jannes H, Nolard N. Environmental investigations and molecular typing of Aspergillus flavus during an outbreak of postoperative infections. J Hosp Infect 2004;57(2):149-55.
135. Triassi M, Di Popolo A, Ribera D'Alcala G, Albanese Z, Cuccurullo S, Montegrosso S, et al. Clinical and environmental distribution of Legionella pneumophila in a university hospital in Italy: efficacy of ultraviolet disinfection. J Hosp Infect 2006;62(4):494-501.
136. Kronman MP, Baden HP, Jeffries HE, Heath J, Cohen GA, Zerr DM. An investigation of Aspergillus cardiac surgical site infections in 3 pediatric patients. Am J Infect Control 2007; 35(5):332-7.
137. Pawar M, Mehta Y, Ansari A, Nair R, Trehan N. Nosocomial infections and balloon counterpulsation: risk factors and outcome. Asian Cardiovasc Thorac Ann 2005;13(4):316-20.
138. Putney LJ. Bloodless cardiac surgery: not just possible, but preferable. Crit Care Nurs Q 2007;30(3):263-70.
139. Rogers MA, Blumberg N, Heal JM, Hicks GL Jr. Increased risk of infection and mortality in women after cardiac surgery related to allogeneic blood transfusion. J Womens Health (Larchmt) 2007;16(10):1412-20.
140. Shander A, Spence RK, Adams D, Shore-Lesserson L, Walawander CA. Timing and incidence of postoperative infections associated with blood transfusion: analysis of 1,489 orthopedic and cardiac surgery patients. Surg Infect (Larchmt) 2009; 10(3):277-83.
141. Andreasen JJ, Dethlefsen C, Modrau IS, Baech J, Schonheyder HC, Moeller JK, et al. Storage time of allogeneic red blood cells is associated with risk of severe postoperative infection after coronary artery bypass grafting. Eur J Cardiothorac Surg 2011;39(3):329-34.
142. Blumberg N, Heal JM, Cowles JW, Hicks GL Jr, Risher WH, Samuel PK, Kirkley SA. Leukocyte-reduced transfusions in cardiac surgery: results of an implementation trial. Am J Clin Pathol 2002;118(3):376-81.
143. Capraro L, Kuitunen A, Vento AE, Suojaranta-Ylinen R, Kolho E, Pettila V. Universal leukocyte reduction of transfused red cells does not provide benefit to patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2007;21(2):232-6.
144. Tavolacci MP, Merle V, Josset V, Bouchart F, Litzler PY, Tabley A, et al. Mediastinitis after coronary artery bypass graft surgery: influence of the mammary grafting for diabetic patients. J Hosp Infect 2003;55(1):21-5.
145. Momin AU, Deshpande R, Potts J, El-Gamel A, Marrinan MT, Omigie J, Desai JB. Incidence of sternal infection in diabetic patients undergoing bilateral internal thoracic artery grafting. Ann Thorac Surg 2005;80(5):1765-72.
146. Farhat F, Metton O, Jegaden O. Benefits and complications of total sternotomy and ministernotomy in cardiac surgery. Surg Technol Int 2004;13:199-205.
147. Aburumman AM. Tilted T ministernotomy: a new approach in cardiac surgery. JRMS 2010;17(2):61-9. Available from: http://www.jrms.gov.jo/Portals/1/Journal/2010/pdf%20 June%202010/65-08%20Aburumman.pdf [cited 2013 Feb 11].
148. Zeitani J, Penta de Peppo A, Moscarelli M, Guerrieri Wolf L, Scafuri A, Nardi P, et al. Influence of sternal size and inadvertent paramedian sternotomy on stability of the closure site: a clinical and mechanical study. J Thorac Cardiovasc Surg 2006;132(1):38-42.
149. Schimmer C, Reents W, Berneder S, Eigel P, Sezer O, Scheld H, et al. Prevention of sternal dehiscence and infection in high-risk patients: a prospective randomized multicenter trial. Ann Thorac Surg 2008;86(6):1897-904.
150. Okutan H, Tenekeci C, Kutsal A. The reinforced sternal closure system is reliable to use in elderly patients. J Card Surg 2005;20(3):271-3.
151. Song DH, Lohman RF, Renucci JD, Jeevanandam V, Raman J. Primary sternal plating in high-risk patients prevents mediastinitis. Eur J Cardiothorac Surg 2004;26(2):367-72.
152. Risnes I, Abdelnoor M, Baksaas ST, Lundblad R, Svennevig JL. Sternal wound infections in patients undergoing open heart surgery: randomized study comparing intracutaneous and transcutaneous suture techniques. Ann Thorac Surg 2001;72(5):1587-91.
153. Karabay O, Fermanci E, Silistreli E, Aykut K, Yurekli I, Catalyurek H, Acikel U. Intracutaneous versus transcutaneous suture techniques: comparison of sternal wound infection rates in open-heart surgery patients. Tex Heart Inst J 2005;32 (3):277-82.
154. Ramzisham AR, Raflis AR, Khairulasri MG, Ooi Su Min J, Fikri AM, Zamrin MD. Figure-of-eight vs. interrupted sternal wire closure of median sternotomy. Asian Cardiovasc Thorac Ann 2009;17(6):587-91.
155. Gorlitzer M, Wagner F, Pfeiffer S, Folkmann S, Meinhart J, Fischlein T, et al. A prospective randomized multicenter trial shows improvement of sternum related complications in cardiac surgery with the Posthorax support vest. Interact Cardiovasc Thorac Surg 2010;10(5):714-8.
156. Bhatti F, Dunning J. Does liberal use of bone wax increase the risk of mediastinitis? Interact Cardiovasc Thorac Surg 2003;2 (4):410-2.
157. Prziborowski J, Hartrumpf M, Stock UA, Kuehnel RU, Albes JM. Is bonewax safe and does it help? Ann Thorac Surg 2008; 85(3):1002-6.
158. Cohen O, Dankner R, Chetrit A, Luxenburg O, Langenauer C, Shinfeld A, Smolinsky AK. Multidisciplinary intervention for control of diabetes in patients undergoing coronary artery bypass graft (CABG). Cardiovasc Surg 2003;11(3):195-200.
159. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004;109(12): 1497-502.
160. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, Williams BA, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005;80(7):862-6.
161. Brown JR, Edwards FH, O'Connor GT, Ross CS, Furnary AP. The diabetic disadvantage: historical outcomes measures in diabetic patients undergoing cardiac surgery--the pre-intravenous insulin era. Semin Thorac Cardiovasc Surg 2006; 18(4):281-8.
162. Furnary AP, Wu Y. Eliminating the diabetic disadvantage: the Portland Diabetic Project. Semin Thorac Cardiovasc Surg 2006;18(4):302-8.
163. Schmeltz LR, DeSantis AJ, Thiyagarajan V, Schmidt K, O'Shea-Mahler E, Johnson D, et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care 2007;30 (4):823-8.
164. Patel KL. Impact of tight glucose control on postoperative infection rates and wound healing in cardiac surgery patients. J Wound Ostomy Continence Nurs 2008;35(4):397-406.
165. Kramer R, Groom R, Weldner D, Gallant P, Heyl B, Knapp R, Arnold A. Glycemic control and reduction of deep sternal wound infection rates: a multidisciplinary approach. Arch Surg 2008;143(5):451-6.
166. Lehwaldt D, Kingston M, O'Connor S. Postoperative hyperglycaemia of diabetic patients undergoing cardiac surgery-a clinical audit. Nurs Crit Care 2009;14(5):241-53.
167. Rogers SO Jr, Zinner MJ. The role of perioperative hyperglycemia in postoperative infections. Adv Surg 2009;43:103-9.
168. Bustamante J, Tamayo E, Alvarez FJ, Garcia-Cuenca I, Florez S, Fierro I, Gomez-Herreras JI. Intraoperative PaO2 is not related to the development of surgical site infections after major cardiac surgery. J Cardiothorac Surg 2011;6:4.
169. Cappabianca G, Rotunno C, de Luca Tupputi Schinosa L, Ranieri VM, Paparella D. Protective effects of steroids in cardiac surgery: a meta-analysis of randomized double-blind trials. J Cardiothorac Vasc Anesth 2011;25(1):156-65.
170. Yoshii S, Hosaka S, Suzuki S, Takahashi W, Okuwaki H, Osawa H, et al. Prevention of surgical site infection by antibiotic spraying in the operative field during cardiac surgery. Jpn J Thorac Cardiovasc Surg 2001;49(5):279-81.
171. Persson M, van der Linden J. Wound ventilation with carbon dioxide: a simple method to prevent direct airborne contamination during cardiac surgery? J Hosp Infect 2004;56(2):131-6.
172. Fleck T, Moidl R, Blacky A, Fleck M, Wolner E, Grabenwoger M, Wisser W. Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations [published erratum appears in Ann Thorac Surg 2007;84(6): 2139]. Ann Thorac Surg 2007;84(1):232-6.
173. Stadler S, Fleck T. Triclosan-coated sutures for the reduction of sternal wound infections? A retrospective observational analysis. Interact Cardiovasc Thorac Surg 2011;13(3):296-9.
174. Isik I, Selimen D, Senay S, Alhan C. Efficiency of antibacterial suture material in cardiac surgery: a double-blind randomized prospective study. Heart Surg Forum 2012;15(1):E40-5.
175. Vander Salm TJ, Okike ON, Pasque MK, Pezzella AT, Lew R, Traina V, Mathieu R. Reduction of sternal infection by application of topical vancomycin. J Thorac Cardiovasc Surg 1989;98(4):618-22.
176. Friberg O, Svedjeholm R, Soderquist B, Granfeldt H, Vikerfors T, Kallman J. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg 2005;79(1):153-62.
177. Eklund AM, Valtonen M, Werkkala KA. Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery. J Hosp Infect 2005;59(2):108-12.
178. Friberg O, Svedjeholm R, Kallman J, Soderquist B. Incidence, microbiological findings, and clinical presentation of sternal wound infections after cardiac surgery with and without local gentamicin prophylaxis. Eur J Clin Microbiol Infect Dis 2007;26(2):91-7.
179. Friberg O. Local collagen-gentamicin for prevention of sternal wound infections: the LOGIP trial. APMIS 2007;115(9): 1016-21.
180. Bennett-Guerrero E, Ferguson TB Jr, Lin M, Garg J, Mark DB, Scavo VA Jr, et al. Effect of an implantable gentamicincollagen sponge on sternal wound infections following cardiac surgery: a randomized trial. JAMA 2010;304(7):755-62.
181. Schimmer C, Ozkur M, Sinha B, Hain J, Gorski A, Hager B, Leyh R. Gentamicin-collagen sponge reduces sternal wound complications after heart surgery: a controlled, prospectively randomized, double-blind study. J Thorac Cardiovasc Surg 2012;143(1):194-200.
182. Creanor S, Barton A, Marchbank A. Effectiveness of a gentamicin impregnated collagen sponge on reducing sternal wound infections following cardiac surgery: a meta-analysis of randomised controlled trials. Ann R Coll Surg Engl 2012;94 (4):227-31.
183. Godbole G, Pai V, Kolvekar S, Wilson AP. Use of gentamicincollagen sponges in closure of sternal wounds in cardiothoracic surgery to reduce wound infections. Interact Cardiovasc Thorac Surg 2012;14(4):390-4.
184. MacIver RH, Stewart R, Frederiksen JW, Fullerton DA, Horvath KA. Topical application of bacitracin ointment is associated with decreased risk of mediastinitis after median sternotomy. Heart Surg Forum 2006;9(5):E750-3.
185. Trowbridge CC, Stammers AH, Woods E, Yen BR, Klayman M, Gilbert C. Use of platelet gel and its effects on infection in cardiac surgery. J Extra Corpor Technol 2005;37(4):381-6.
186. Englert SJ, Estep TH, Ellis-Stoll CC. Postoperative surgical chest and leg incision sites using platelet gel: a retrospective study. J Extra Corpor Technol 2008;40(4):225-8.
187. Souza EC, Fitaroni RB, Januzelli DM, Macruz HM, Camacho JC, Souza MR. Use of 2-octyl cyanoacrylate for skin closure of sternal incisions in cardiac surgery: observations of microbial barrier effects. Curr Med Res Opin 2008;24(1): 151-5.
188. Basaran M, Kafali E, Ugurlucan M, Kalko Y, Selimoglu O, Us MH, Ogus TN. Cyanoacrylate gluing increases the effectiveness of systemic antimicrobial treatment in sternal infection: experimental study in a rodent model. Thorac Cardiovasc Surg 2008;56(1):28-31.
189. Dohmen PM, Gabbieri D, Weymann A, Linneweber J, Konertz W. Reduction in surgical site infection in patients treated with microbial sealant prior to coronary artery bypass graft surgery: a case-control study. J Hosp Infect 2009;72(2):119-26.
190. Chambers A, Scarci M. Is skin closure with cyanoacrylate glue effective for the prevention of sternal wound infections? Interact Cardiovasc Thorac Surg 2010;10(5):793-6.
191. Dohmen PM, Gabbieri D, Weymann A, Linneweber J, Geyer T, Konertz W. A retrospective non-randomized study on the impact of INTEGUSEAL, a preoperative microbial skin sealant, on the rate of surgical site infections after cardiac surgery. Int J Infect Dis 2011;15(6):e395-400.
192. von Eckardstein AS, Lim CH, Dohmen PM, Pego-Fernandes PM, Cooper WA, Oslund SG, Kelley EL. A randomized trial of a skin sealant to reduce the risk of incision contamination in cardiac surgery. Ann Thorac Surg 2011;92(2):632-7.
193. Dohmen PM, Weymann A, Holinski S, Linneweber J, Geyer T, Konertz W. Use of an antimicrobial skin sealant reduces surgical site infection in patients undergoing routine cardiac surgery. Surg Infect (Larchmt) 2011;12(6):475-81.
194. Waldow T, Szlapka M, Hensel J, Plotze K, Matschke K, Jatzwauk L. Skin sealant InteguSeal(R) has no impact on pre vention of postoperative mediastinitis after cardiac surgery. J Hosp Infect 2012;81(4):278-82.
195. Datta R, Platt R, Yokoe DS, Huang SS. Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch Intern Med 2011; 171(6):491-4.
196. Le Guillou V, Tavolacci MP, Baste JM, Hubscher C, Bedoit E, Bessou JP, Litzler PY. Surgical site infection after central venous catheter-related infection in cardiac surgery. Analysis of a cohort of 7557 patients. J Hosp Infect 2011;79(3):236-41.
197. El-Hamamsy I, Durrleman N, Stevens LM, Leung TK, Theoret S, Carrier M, Perrault LP. Incidence and outcome of radial artery infections following cardiac surgery. Ann Thorac Surg 2003;76(3):801-4.
198. San Juan R, Aguado JM, Lopez MJ, Lumbreras C, Enriquez F, Sanz F, et al. Accuracy of blood culture for early diagnosis of mediastinitis in febrile patients after cardiac surgery. Eur J Clin Microbiol Infect Dis 2005;24(3):182-9.
199. Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM. Intravenous iron following cardiac surgery does not increase the infection rate. Surg Infect (Larchmt) 2006;7(4):361-6.
200. Elahi MM, Haesey AM, Graham KC, Battula NR, Manketlow B, Dhannapuneni RR, Hickey MS. Leg wound infections following cardiac surgery: a scoring system for assessment and management. J Wound Care 2005;14(7):337-40.
201. Wynne R, Botti M, Stedman H, Holsworth L, Harinos M, Flavell O, Manterfield C. Effect of three wound dressings on infection, healing comfort, and cost in patients with sternotomy wounds: a randomized trial. Chest 2004;125(1):43-9.
202. Segers P, de Jong AP, Spanjaard L, Ubbink DT, de Mol BA. Randomized clinical trial comparing two options for postoperative incisional care to prevent poststernotomy surgical site infections [published erratum appears in Wound Repair Regen 2007;15(3):430]. Wound Repair Regen 2007;15(2): 192-6.
203. Huckfeldt R, Redmond C, Mikkelson D, Finley PJ, Lowe C, Robertson J. A clinical trial to investigate the effect of silver nylon dressings on mediastinitis rates in postoperative cardiac sternotomy incisions. Ostomy Wound Manage 2008;54(10): 36-41.
204. Mehta RH, Sheng S, O'Brien SM, Grover FL, Gammie JS, Ferguson TB, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes 2009;2(6):583-90.
205. Boeken U, Eisner J, Feindt P, Petzold TH, Schulte HD, Gams E. Does the time of resternotomy for bleeding have any influence on the incidence of sternal infections, septic courses or further complications? Thorac Cardiovasc Surg 2001;49(1): 45-8.
206. Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg 2004;78(2):527-34.
207. Charalambous CP, Zipitis CS, Keenan DJ. Chest reexploration in the intensive care unit after cardiac surgery: a safe alternative to returning to the operating theater. Ann Thorac Surg 2006;81(1):191-4.
208. Yap EL, Levine A, Strang T, Dunning J. Should additional antibiotics or an iodine washout be given to all patients who suffer an emergency re-sternotomy on the cardiothoracic intensive care unit? Interact Cardiovasc Thorac Surg 2008;7(3): 464-9.
209. Lutarewych M, Morgan SP, Hall MM. Improving outcomes of coronary artery bypass graft infections with multiple interventions: putting science and data to the test. Infect Control Hosp Epidemiol 2004;25(6):517-9.
210. Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, et al. Surgical site infection rates following cardiac surgery: the impact of a 6-year infection control program. Am J Infect Control 2005;33(8):450-4.
211. Gardlund B. Postoperative surgical site infections in cardiac surgery--an overview of preventive measures. APMIS 2007; 115(9):989-95.
212. Beckmann A, Doebler K, Schaefer E, Koetting J, Gastmeier P, Graf K. Sternal surgical site infection prevention-is there any room for improvement? Eur J Cardiothorac Surg 2011;40 (2):347-51.
213. Rosenberger LH, Politano AD, Sawyer RG. The surgical care improvement project and prevention of post-operative infection, including surgical site infection. Surg Infect (Larchmt) 2011;12(3):163-8.